A phase 3 study to evaluate the Efficacy and Safety of KEVEYIS (dichlorphenamide) in Adolescent Patients with Primary Periodic Paralysis.

Trial Profile

A phase 3 study to evaluate the Efficacy and Safety of KEVEYIS (dichlorphenamide) in Adolescent Patients with Primary Periodic Paralysis.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Mar 2018

At a glance

  • Drugs Diclofenamide (Primary)
  • Indications Paralysis
  • Focus Therapeutic Use
  • Acronyms Study 1
  • Most Recent Events

    • 09 Mar 2018 New trial record
    • 05 Mar 2018 According to a Strongbridge Biopharma media release, Perry B. Shieh, M.D, associate professor of the neuromuscular program at the University of California at Los Angeles, is the principal investigator of the study.
    • 05 Mar 2018 Results presented in the Strongbridge Biopharma Media Release
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top